Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the introduction of a new range of StarBright Dyes, ...

High dimensional full spectrum flow cytometry holds the promise of addressing long-held questions in cellular biology. Fluorescent dye performance heavily impacts both the quality and the ...

NovaFluor dyes are novel fluorophores for flow cytometry, designed with narrow emission spectra and minimal cross-laser excitation. NovaFluor dyes are engineered to emit at specific intervals and can ...

Flow cytometry experiments are measuring more variables than ever, pushing the technical limits of conventional flow cytometry. Spectral flow cytometry enables multicolor panels with more parameters ...

Over the last two weeks, companies have unveiled enhanced panel design capabilities for spectral flow cytometry and same-cell RNA and protein analysis for the advancement of spatial biology. We’ve ...

Today Cytek Biosciences, Inc. (Nasdaq: CTKB) announced that it has developed a revolutionary tool to automate panel design. The company has expanded the capabilities of the Panel Builder tool within ...

Flow cytometry remains a critical technology for the high-throughput analysis of single cells in complex populations. Attention to good analysis practices is more important than ever due to the recent ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) has announced the NovoCyte Opteon Spectral Flow Cytometer, propelling flow cytometry into a new era of and accessibility. This ...

A 24-parameter spectral flow cytometry panel was developed to monitor immune receptor expression in MS patients, aiding personalized treatment approaches. The panel detects 12 treatment-associated ...

Flow cytometry continues to evolve, yet many experiments are still limited by avoidable issues in panel design, control selection, reagent handling, and instrument understanding. As analytical ...

Beckman Coulter Life Sciences, a Danaher company and a global leader in laboratory automation and innovation, announces the launch of its new IR820 and IR870 infrared dye antibody conjugates. For the ...

Not all patients respond well to chimeric antigen receptor (CAR) T cell therapies, which reprogram a patient’s own immune cells to recognize and attack cancer. A way to optimize these treatments is to ...